The E3 ubiquitin ligase RNF 114 and TAB 1 degradation are required for maternal‐to‐zygotic transition
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The functional role of the ubiquitin‐proteasome pathway during maternal‐to‐zygotic transition (MZT) remains to be elucidated. Here we show that the E3 ubiquitin ligase, Rnf114, is highly expressed in mouse oocytes and that knockdown of Rnf114 inhibits development beyond the two‐cell stage. To study the underlying mechanism, we identify its candidate substrates using a 9,000‐protein microarray and validate them using an in vitro ubiquitination system. We show that five substrates could be degraded by RNF114‐mediated ubiquitination, including TAB1. Furthermore, the degradation of TAB1 in mouse early embryos is required for MZT, most likely because it activates the NF‐κB pathway. Taken together, our study uncovers that RNF114‐mediated ubiquitination and degradation of TAB1 activate the NF‐κB pathway during MZT, and thus directly link maternal clearance to early embryo development. The E3 ubiquitin ligase RNF114 promotes TAB1 ubiquitination and degradation, and both RNF114 and TAB1 downregulation are required for maternal‐to‐zygotic transition of mouse embryos. The E3 ubiquitin ligase RNF114 promotes TAB1 ubiquitination and degradation, and both RNF114 and TAB1 downregulation are required for maternal‐to‐zygotic transition of mouse embryos.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Komander, D., & Rape, M. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060310-170328 · Cited by 3,679 · cited 1×
“Well-accepted doctrine substrates modified with Lys48 or Lys11 polyubiquitin chains can be targeted to the proteasome for degradation, but this does not apply to other linkages [22,23].”
TAK1 is a ubiquitin-dependent kinase of MKK and IKK
Wang, C., Deng, L., Hong, M., Akkaraju, G. R., Inoue, J.-I., & Chen, Z. J. (2001) · Nature · doi:10.1038/35085597 · Cited by 2,125
Cited by
The maternal-to-zygotic transition revisited
Vastenhouw, N. L., Cao, W. X., & Lipshitz, H. D. (2019) · Development · doi:10.1242/dev.161471 · Cited by 445
Harnessing the anti-cancer natural product nimbolide for targeted protein degradation
Spradlin, J. N., Hu, X., Ward, C. C., Brittain, S. M., Jones, M. D., Ou, L., To, M., Proudfoot, A., Ornelas, E., Woldegiorgis, M., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0304-8 · Cited by 432
Dynamics of the epigenetic landscape during the maternal-to-zygotic transition
Eckersley-Maslin, M. A., Alda-Catalinas, C., & Reik, W. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0008-z · Cited by 431
An overview of PROTACs: a promising drug discovery paradigm
Liu, Z., Hu, M., Yang, Y., Du, C., Zhou, H., Liu, C., Chen, Y., Fan, L., Ma, H., Gong, Y., et al. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00112-0 · Cited by 344
Self-citationIdentification of RNF114 as ADPr-Ub reader through non-hydrolysable ubiquitinated ADP-ribose
Kloet, M. S., Chatrin, C., Mukhopadhyay, R., van Tol, B. D. M., Smith, R., Rotman, S. A., Tjokrodirijo, R. T. N., Zhu, K., Gorelik, A., Maginn, L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61111-7 · Cited by 30
Metadata
- Authors
- Yang, Y., Zhou, C., Wang, Y., Liu, W., Liu, C., Wang, L., Liu, Y., Shang, Y., Li, M., Zhou, S., Wang, Y., Zeng, W., Zhou, J., Huo, R., & Li, W.
- Venue
- EMBO reports
- Published
- 2017-01-10
- Volume
- 18
- Issue
- 2
- Pages
- 205-216
- ISSN
- 1469-221X (ISSN-L)
- 1469-3178
- OpenAlex
- W2569472949
- Cited by
- 61
- References
- 2
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The E3 ubiquitin ligase RNF 114 and TAB 1 degradation are required for maternal‐to‐zygotic transition. https://app.cochat.ai/papers/10.15252/embr.201642573
- The paper
- Yang, Y., Zhou, C., Wang, Y., Liu, W., Liu, C., Wang, L., Liu, Y., Shang, Y., Li, M., Zhou, S., Wang, Y., Zeng, W., Zhou, J., Huo, R., & Li, W. (2017). The E3 ubiquitin ligase RNF 114 and TAB 1 degradation are required for maternal‐to‐zygotic transition. EMBO reports. https://doi.org/10.15252/embr.201642573
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.